UKRI is supporting hundreds of projects that are addressing the key challenges of coronavirus: we have invested more than £400 million in new research and innovation, which tackles the COVID-19 pandemic and its many impacts on business, the economy and society.
This includes major breakthroughs such as:
- identifying the world’s first treatments for COVID-19
- leading the global effort to find a vaccine
- accelerating the UK’s vaccine manufacturing capacity.
We are also funding a diverse range of projects that address the wider consequences – from mental health issues to economic and environmental impacts – as well as helping innovative businesses through these tough times.
Our impact is built on the strength of the UK’s world-class research base and the long-term support from our councils. This is a collective endeavour, with UKRI playing a key role in convening and catalysing efforts to respond to the crisis.